Kiecker, who joined the FSIS in 1988 as a food inspector, most recently was appointed FSIS administrator in 2020 and previously worked as its acting administrator until January 2019. He also served in other roles with the agency, including serving in regulatory operations and working as district and deputy district manager in several states. He also worked with the Office of Investigation, Enforcement, and Audit as a compliance investigator and as a supervisory compliance officer.
In addition to serving as the acting FDA Commissioner, she is director of the Center for Drug Evaluation and Research (CDER), a department of the FDA.Woodcock joined the FDA in 1986 and has held a number of senior leadership positions, including terms as the Director of CDER from 1994 to 2004 and from 2007–2020.
The National Consumers League called her “a passionate advocate for American patients and consumers, an ally to patient advocacy groups, and a fearless leader at the FDA.”
Woodcock, 72, has overseen changes to both CDER and FDA, including a new initiative to improve the timeliness and transparency of FDA procedures, and the safety, quality, and effectiveness of drugs.In 2015, Woodcock received a Lifetime Achievement Award from the Institute for Safe Medication Practices, in recognition of “a significant career history of making ongoing contributions to patient safety.”
(To sign up for a free subscription to Food Safety News, click here.)